Literature DB >> 16148934

The most infectious prion protein particles.

Jay R Silveira1, Gregory J Raymond, Andrew G Hughson, Richard E Race, Valerie L Sim, Stanley F Hayes, Byron Caughey.   

Abstract

Neurodegenerative diseases such as Alzheimer's, Parkinson's and the transmissible spongiform encephalopathies (TSEs) are characterized by abnormal protein deposits, often with large amyloid fibrils. However, questions have arisen as to whether such fibrils or smaller subfibrillar oligomers are the prime causes of disease. Abnormal deposits in TSEs are rich in PrP(res), a protease-resistant form of the PrP protein with the ability to convert the normal, protease-sensitive form of the protein (PrP(sen)) into PrP(res) (ref. 3). TSEs can be transmitted between organisms by an enigmatic agent (prion) that contains PrP(res) (refs 4 and 5). To evaluate systematically the relationship between infectivity, converting activity and the size of various PrP(res)-containing aggregates, PrP(res) was partially disaggregated, fractionated by size and analysed by light scattering and non-denaturing gel electrophoresis. Our analyses revealed that with respect to PrP content, infectivity and converting activity peaked markedly in 17-27-nm (300-600 kDa) particles, whereas these activities were substantially lower in large fibrils and virtually absent in oligomers of < or =5 PrP molecules. These results suggest that non-fibrillar particles, with masses equivalent to 14-28 PrP molecules, are the most efficient initiators of TSE disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16148934      PMCID: PMC1513539          DOI: 10.1038/nature03989

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  24 in total

1.  Unusual resistance to ionizing radiation of the viruses of kuru, Creutzfeldt-Jakob disease, and scrapie.

Authors:  C J Gibbs; D C Gajdusek; R Latarjet
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

Review 2.  Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders.

Authors:  Byron Caughey; Peter T Lansbury
Journal:  Annu Rev Neurosci       Date:  2003-04-09       Impact factor: 12.449

3.  A solid-phase assay for identification of modulators of prion protein interactions.

Authors:  Laura Maxson; Caíne Wong; Lynn M Herrmann; Byron Caughey; Gerald S Baron
Journal:  Anal Biochem       Date:  2003-12-01       Impact factor: 3.365

4.  The exceptionally small size of the scrapie agent.

Authors:  T Alper; D A Haig; M C Clarke
Journal:  Biochem Biophys Res Commun       Date:  1966-02-03       Impact factor: 3.575

5.  On the mechanism of alpha-helix to beta-sheet transition in the recombinant prion protein.

Authors:  M Morillas; D L Vanik; W K Surewicz
Journal:  Biochemistry       Date:  2001-06-12       Impact factor: 3.162

6.  Purified prion proteins and scrapie infectivity copartition into liposomes.

Authors:  R Gabizon; M P McKinley; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

7.  Efficient inhibition of prion replication by PrP-Fc(2) suggests that the prion is a PrP(Sc) oligomer.

Authors:  Joanna Masel; Nicolas Genoud; Adriano Aguzzi
Journal:  J Mol Biol       Date:  2004-12-08       Impact factor: 5.469

8.  New inhibitors of scrapie-associated prion protein formation in a library of 2000 drugs and natural products.

Authors:  David A Kocisko; Gerald S Baron; Richard Rubenstein; Jiancao Chen; Salomon Kuizon; Byron Caughey
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 9.  Prion protein and the molecular features of transmissible spongiform encephalopathy agents.

Authors:  J R Silveira; B Caughey; G S Baron
Journal:  Curr Top Microbiol Immunol       Date:  2004       Impact factor: 4.291

10.  Molecular properties, partial purification, and assay by incubation period measurements of the hamster scrapie agent.

Authors:  S B Prusiner; D F Groth; S P Cochran; F R Masiarz; M P McKinley; H M Martinez
Journal:  Biochemistry       Date:  1980-10-14       Impact factor: 3.162

View more
  332 in total

1.  The α-helical C-terminal domain of full-length recombinant PrP converts to an in-register parallel β-sheet structure in PrP fibrils: evidence from solid state nuclear magnetic resonance.

Authors:  Robert Tycko; Regina Savtchenko; Valeriy G Ostapchenko; Natallia Makarava; Ilia V Baskakov
Journal:  Biochemistry       Date:  2010-11-09       Impact factor: 3.162

2.  Stable and metastable states of human amylin in solution.

Authors:  Allam S Reddy; Lu Wang; Sadanand Singh; Yun L Ling; Lauren Buchanan; Martin T Zanni; James L Skinner; Juan J de Pablo
Journal:  Biophys J       Date:  2010-10-06       Impact factor: 4.033

3.  Tracking protein aggregation and mislocalization in cells with flow cytometry.

Authors:  Yasmin M Ramdzan; Saskia Polling; Cheryl P Z Chia; Ivan H W Ng; Angelique R Ormsby; Nathan P Croft; Anthony W Purcell; Marie A Bogoyevitch; Dominic C H Ng; Paul A Gleeson; Danny M Hatters
Journal:  Nat Methods       Date:  2012-03-18       Impact factor: 28.547

4.  Direct observation of multiple misfolding pathways in a single prion protein molecule.

Authors:  Hao Yu; Xia Liu; Krishna Neupane; Amar Nath Gupta; Angela M Brigley; Allison Solanki; Iveta Sosova; Michael T Woodside
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-15       Impact factor: 11.205

Review 5.  New generation QuIC assays for prion seeding activity.

Authors:  Christina D Orrù; Jason M Wilham; Sarah Vascellari; Andrew G Hughson; Byron Caughey
Journal:  Prion       Date:  2012-04-01       Impact factor: 3.931

6.  Dynamics of a truncated prion protein, PrP(113-231), from (15)N NMR relaxation: order parameters calculated and slow conformational fluctuations localized to a distinct region.

Authors:  Denis B D O'Sullivan; Christopher E Jones; Salama R Abdelraheim; Marcus W Brazier; Harold Toms; David R Brown; John H Viles
Journal:  Protein Sci       Date:  2009-02       Impact factor: 6.725

7.  The region approximately between amino acids 81 and 137 of proteinase K-resistant PrPSc is critical for the infectivity of the Chandler prion strain.

Authors:  Ryo Shindoh; Chan-Lan Kim; Chang-Hyun Song; Rie Hasebe; Motohiro Horiuchi
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

Review 8.  Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions.

Authors:  Byron Caughey; Gerald S Baron; Bruce Chesebro; Martin Jeffrey
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

Review 9.  Prion diseases and their biochemical mechanisms.

Authors:  Nathan J Cobb; Witold K Surewicz
Journal:  Biochemistry       Date:  2009-03-31       Impact factor: 3.162

10.  Separate mechanisms act concurrently to shed and release the prion protein from the cell.

Authors:  Lotta Wik; Mikael Klingeborn; Hanna Willander; Tommy Linne
Journal:  Prion       Date:  2012-10-23       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.